H.-J. Cong et al. / Phytochemistry 100 (2014) 76–85
83
Compounds 1–10 were evaluated for cytotoxicity against four
rahydro-b-carboline-3-carboxylic acid (20 mg). Fraction I was sub-
human cancer cell lines. However, these compounds did not exhi-
jected to LH-20 CC (MeOH) to give fractions (I1 and I2). Fraction I2
bit significant cytotoxicity (IC50 > 10
(IC50 < 10 nM, Table 4).
l
M), compared to vinorelbin
was separated by RP-HPLC (YMC 5
l
m, 250 ꢁ 10 mm, H2O–CH3CN,
87:13, v/v, 3.0 mL/min, eluting at 10–12 min, UV 254 nm) to yield
compound 3 (60 mg). Fraction J was subjected to C18 CC eluted with
H2O–MeOH (80:20 to 60:40, v/v) to give compound 5-carboxy-
strictosidine (500 mg) and desoxycordifoline (9 mg). Fraction K
was applied to a C18 column eluted with H2O–MeOH (80:20 to
50:50, v/v) to give fractions (K1, K2 and K3). Fraction K1 was sepa-
Conclusions
Ten terpenoid indole alkaloids, mappiodines A-C (1–3) and
mappiodosides A-G (4–10), together with eight known com-
pounds, were isolated from stems of M. iodoides. Their structures
were elucidated by intensive spectroscopic analyses. In previous
phytochemical investigations, five monoterpenoid indole alkaloids
were isolated from M. iodoides stems (Xiao et al., 2011). The find-
ings herein thus complement previous reports of the occurrence
of terpenoid indole alkaloids in the Mappianthus genus. It is
concluded that the rich source of terpenoid indole alkaloids in M.
iodoides might be a useful chemotaxonomic marker of the Map-
pianthus genus.
rated by RP-HPLC (YMC 5
v/v, 3.0 mL/min, eluting at 14–34 min, UV 254 nm) to yield com-
l
m, 250 ꢁ 10 mm, H2O–CH3CN, 85:15,
pound 8 (40 mg) and 9 (25 mg). Fraction K2 was separated by RP-
HPLC (YMC 5
l
m, 250 ꢁ 10 mm, H2O–MeOH, 55:45, v/v, 3.0 mL/
min, eluting at 6.5–12.5 min, UV 254 nm) to yield compound 7
(50 mg) and strictosidinic acid (35 mg). Fraction K3 was separated
by RP-HPLC (YMC 5
3.0 mL/min, eluting at 8–17 min, UV 254 nm) to yield compound
5 (60 mg) and 3 , 5 -tetrahydrodeoxycordifolic acid (20 mg). Frac-
tion L was subjected to a C18 CC eluted with H2O–MeOH (80:20 to
45:55, v/v) to give compound 2 (71 mg) and 3 , 5 -tetrahydrode-
l
m, 250 ꢁ 10 mm, H2O–CH3CN, 84:16, v/v,
a
a
a
a
Experimental
oxycordifoline (55 mg). Fraction M was applied to a C18 CC eluted
with H2O–MeOH (80:20 to 40:60, v/v) to give lyaloside (45 mg).
General
Mappiodine A (1)
Yellow amorphous powder, ½a D23
ꢀ4.0 (c 0.15, MeOH), UV
ꢂ
Optical rotations were measured on a Perkin-Elmer 341 polar-
imeter, whereas UV and IR spectra were recorded on a Shimadzu
UV-2450 and a Perkin-Elmer 577 spectrophotometer, respectively.
NMR spectra were acquired on a Varian Mercury NMR spectrome-
ter operating at 500 MHz for 1H and 125 MHz for 13C. HRESIMS was
measured using an Agilent G6224A TOF spectrometer. Thin-layer
chromatography (TLC) used precoated silicagel GF254 plates (Yan-
tai, People’s Republic of China). Column chromatography (CC) used
(MeOH) (loge) kmax 206 (3.96), 274 (3.58), 311 (3.42); IR (KBr) mmax
3407, 2924, 1724, 1628, 1460, 1383, 1201, 1073, 1041 cmꢀ1; for
13C and 1H NMR spectroscopic data, see Tables 1 and 2. HRESIMS:
m/z 417.2016 [M+H]+ (calcd for C22H29N2O6 +, 417.2020).
Mappiodine B (2)
Yellow amorphous powder, ½a D24
ꢂ
+49.0 (c 0.13, MeOH), UV
Sephadex LH-20 (20–80
Chromatorex C18-OPN (20–45
MCI gel CHP20P (75–150 m, Mitsubishi Chemical Industries Co.,
lm; Amersham Pharmacia Biotech AB),
(MeOH) (loge) kmax 210 (4.06), 233 (4.07), 273 (3.92), 314 (3.94);
lm; Fuji Silysia Chemical Ltd.) and
IR (KBr) mmax 3399, 3089, 1675, 1637, 1577, 1506, 1454, 1328,
1200, 1128, 821, 719 cmꢀ1; for 13C and 1H NMR spectroscopic data,
see Tables 1 and 2. HRESIMS: m/z 351.1340 [M+H]+ (calcd for
l
Ltd.), respectively. b-Cellulase was manufactured by Sinopharm
Chemical Reagent Co., Ltd., Shanghai, People’s Republic of China.
C
20H19N2O4+, 351.1339).
Plant material
Mappiodine C (3)
Yellow amorphous powder, ½a D24
ꢂ
-68.1 (c 0.3, MeOH), UV
Stems of Mappianthus iodoides were collected from Nanning, in
Guangxi Province, PR China, in September 2011, and authenticated
by Prof. Heming Yang. A voucher specimen (No. SIMMMI78) is
deposited at the Herbarium of Shanghai Institute of Materia
Medica, Chinese Academy of Sciences, PR China.
(MeOH) (loge) kmax 224 (4.59), 275 (4.09); IR (KBr) mmax 3420,
2922, 2872, 1630, 1460, 1392, 1209, 1075, 1039 cmꢀ1; for 13C
and 1H NMR spectroscopic data, see Tables 1 and 2. HRESIMS: m/
z 399.1559 [M+H]+ (calcd for C21H23N2O6+, 399.1551).
Mappiodoside A (4)
Extraction and isolation
Yellow amorphous powder, ½a D23
ꢂ
-12.2 (c 0.3, MeOH), UV
(MeOH) (loge) kmax 209 (3.84), 270 (3.48), 311 (3.29); IR (KBr) mmax
Air-dried, powdered stems (5.0 kg) of M. iodoides were extracted
with acetone-H2O (3 ꢁ 20 L, 7:3, v/v, 3 times) at room temperature
for 48 h, respectively. The combined extracts were concentrated to
give a crude extract (420 g), which was partitioned between CHCl3
and H2O to obtain a water-soluble fraction (300 g). The latter was
applied to a MCI gel CHP20P column eluted with H2O–MeOH
(100:0; 80:20; 60:40; 40:60; 0:100, v/v). Fourteen major fractions
(A–N) were obtained. Fraction F was applied to C18 CC, eluted with
H2O–MeOH (90:10 to 80:20, v/v) to give fractions (F1, F2 and F3).
Fraction F1 was further subjected to MCI gel CHP20P CC with
H2O-MeOH (90:10 to 70:30, v/v) to afford 6 (30 mg). Fraction F2
3408, 2923, 1724, 1627, 1459, 1382, 1201, 1074, 1041 cmꢀ1; for
13C and 1H NMR spectroscopic data, see Tables 1 and 2. HRESIMS:
m/z 579.2542 [M+H]+ (calcd for C28H39N2O11+, 579.2548).
Mappiodoside B (5)
Yellow amorphous powder, ½a D24
ꢂ
+11.7 (c 0.1, MeOH), UV
(MeOH) (loge) kmax 210 (3.70), 234 (3.65), 262 (3.55), 312 (3.52);
IR (KBr) mmax 3400, 3089, 1676, 1637, 1577, 1506, 1454, 1329,
1199, 1128 cmꢀ1; for 13C and 1H NMR spectroscopic data, see Ta-
bles
1
and 2. HRESIMS: m/z 513.1875 [M+H]+ (calcd for
C
26H29N2O9+, 513.1868).
was further separated by RP-HPLC (YMC 5
l
m, 250 ꢁ 10 mm,
H2O–MeOH, 75:25, v/v, 3.0 mL/min, eluting at 8.0–15.0 min, UV
254 nm) to yield compound 1 (52 mg) and 4 (40 mg). Fraction F3
was further subjected to MCI gel CHP20P CC with H2O–MeOH
(90:10 to 70:30, v/v) to afford tryptophan (60 mg) and 10
(28 mg). Fraction H was subjected to a C18 CC eluted with H2O-
MeOH (80:20 to 60:40, v/v) to give compound 1-methyl-1,2,3,4-tet-
Mappiodoside C (6)
Yellow amorphous powder, ½a D23
ꢀ18.7 (c 0.2, MeOH), UV
ꢂ
(MeOH) (loge) kmax 225 (4.37), 272 (3.81); IR (KBr) mmax 3419,
2921, 2871, 1629, 1460, 1392, 1209, 1076, 1039, 611 cmꢀ1; for
13C and 1H NMR spectroscopic data, see Tables 1 and 3. HRESIMS:
m/z 561.2085 [M+H]+ (calcd for C27H33N2O11+, 561.2079).